Seattle Genetics, Inc. is a company in the U.S. stock market and it is a holding in 82 U.S.-traded ETFs. SGEN has around 8.5M shares in the U.S. ETF market. The largest ETF holder of SGEN is the iShares NASDAQ Biotechnology ETF (IBB), with approximately 1.60M shares. Investors may also find of interest that the ETF with the largest allocation to SGEN stock is Loncar Cancer Immunotherapy ETF (CNCR), with a portfolio weight of 3.53%. On average, U.S. ETFs allocate 0.40% of SGEN to their portfolios.
Additionally, SGEN is a favorite stock for Vanilla and Growth ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with SGEN as a holding is the iShares Morningstar Mid-Cap Growth ETF (JKH), with a return of 15.00%.